Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rutin-Doped Hybrid Nanoparticles: Effect of the Molecular Doping Density on <i>T</i><sub>1</sub> Relaxivity and Their Application in Targeted Magnetic Resonance Imaging of Malignant Tumors.

Nano letters·2026
Same author

T‑Cell Immunoreceptor with Ig and Immunoreceptor Tyrosine-Based Inhibitory Motif Domains/Cluster of Differentiation 40 Cellular Nanovesicles Carrying Oxaliplatin Exhibited Superior Pancreatic Cancer Cells Therapy.

ACS pharmacology & translational science·2026
Same author

Macrocyclic Pyclen-Based Hybrid Nanoprobes for Magnetic Resonance Imaging of Sentinel Lymph Node Metastasis.

ACS applied materials & interfaces·2026
Same author

Platinum(IV)-Backboned Polymer Prodrug-Functionalized Manganese Oxide Nanoparticles for Enhanced Lung Cancer Chemoimmunotherapy via Amplifying Stimulator of Interferon Genes Activation.

ACS nano·2025
Same author

One-Pot Fabrication of Kinetically Inert Ultrasmall Manganese(II) Chelate-Backboned Polymer Contrast Agents for High-Performance Magnetic Resonance Imaging.

Nano letters·2024
Same author

Effects of Different Carbohydrate Content Diet on Gut Microbiota and Aortic Calcification in Diabetic Mice.

Diabetes, metabolic syndrome and obesity : targets and therapy·2024

Related Experiment Video

Updated: Jun 19, 2026

Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles
08:35

Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles

Published on: January 4, 2012

Engineered Cell Membrane-Coated Nanoparticles: A New Strategy for Pancreatic Cancer Therapy.

Ke Zhou1,2, Zining Zhang1, Bo Wang1

  • 1Institute of Medical Imaging and Artificial Intelligence, Jiangsu University, Zhenjiang 212013, P. R. China.

ACS Pharmacology & Translational Science
|June 18, 2026
PubMed
Summary

Cell membrane-coated nanoparticles offer a promising biomimetic strategy to overcome challenges in pancreatic cancer (PDAC) treatment, enhancing drug delivery and therapeutic efficacy. This approach shows potential for improving diagnosis, overcoming chemotherapy resistance, and remodeling the tumor microenvironment.

Keywords:
cell membrane-coated nanoparticlespancreatic ductal adenocarcinomatherapy

More Related Videos

Surface Engineering of Pancreatic Islets with a Heparinized StarPEG Nanocoating
05:35

Surface Engineering of Pancreatic Islets with a Heparinized StarPEG Nanocoating

Published on: June 23, 2018

Related Experiment Videos

Last Updated: Jun 19, 2026

Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles
08:35

Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles

Published on: January 4, 2012

Surface Engineering of Pancreatic Islets with a Heparinized StarPEG Nanocoating
05:35

Surface Engineering of Pancreatic Islets with a Heparinized StarPEG Nanocoating

Published on: June 23, 2018

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Oncology

Background:

  • Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive cancer with poor patient outcomes.
  • Current PDAC treatment is hindered by diagnostic challenges, a dense tumor microenvironment, and resistance to chemotherapy.
  • Cell membrane-coated nanoparticles represent a biomimetic drug delivery system with potential to address these limitations.

Purpose of the Study:

  • To systematically review the development and application of cell membrane-coated nanoparticles for PDAC treatment.
  • To explore strategies for enhancing nanoparticle targeting and therapeutic synergy.
  • To discuss the potential and challenges of translating this technology for clinical use in PDAC.

Main Methods:

  • Review of literature on cell membrane sources, preparation, and characterization of nanoparticles.
  • Analysis of membrane functionalization techniques (physical, chemical, genetic engineering).
  • Summary of applications in overcoming chemotherapy resistance, physical therapy synergy, and immune microenvironment remodeling for PDAC.

Main Results:

  • Cell membrane-coating enhances nanoparticle circulation time and tumor accumulation via immune evasion and active targeting.
  • Functionalization strategies improve targeting precision and enable combination therapies.
  • These nanoparticles show promise in enhancing chemotherapy efficacy, synergizing with physical therapies, and modulating the tumor immune microenvironment.

Conclusions:

  • Cell membrane-coated nanoparticles hold significant potential for improving PDAC diagnosis and therapy.
  • Further research is needed to address standardization and safety concerns for clinical translation.
  • Interdisciplinary collaboration is crucial for overcoming the challenges in bringing this technology to patients.